Cosmetics

The Netherlands: New borderline products advisory group established

Iradj Nazaryar

On 9 July 2018, the establishment of the new Advisory Group on the Determination of the Status of Borderline Products was published in the Dutch Government Gazette. The Advisory Group consists of expert representatives from the Healthcare and Youth Inspectorate, the Dutch Food and Consumer Product Safety Authority, the Medicines Evaluation Board and the Central Committee Read More

ANSM recommendations prohibit use of umbrella brands with respect to health products in France

Eveline Van Keymeulen

Last week, the French National Agency for Medicines and Health Products Safety (ANSM) published its final recommendations for applicants and holders of marketing authorisations (MA) on the choice of medicinal product names (the Recommendations). The Recommendations were issued following a public consultation by the ANSM in October-November 2016 (see our previous blog post: ANSM opens Read More

Suppliers of luxury goods can restrict online sales on (discernible) third-party platforms, says the Court of Justice

Florence Ninane

The European Court of Justice (ECJ) handed down yesterday its much awaited ruling in Coty Germany GmbH (C-230/16). It has clarified that a supplier of luxury goods can include a clause in selective distribution agreements prohibiting authorised distributors from selling those goods through non-authorised third-party platforms in a discernible manner, in order to preserve the Read More

UK position on Continuity in the Availability of Goods for the EU and the UK set out as Brexit negotiations continue

Erin Currie

A number of position papers have recently been published as negotiations continue on the UK’s withdrawal from the EU.  One such position paper from the UK is the Continuity in the availability of goods for the EU and the UK, published on 21 August 2017, which sets out proposals that will be applicable to the Read More

EU sets out its position in Brexit negotiations on Intellectual Property Rights (including geographical indications)

Erin Currie

On 7 September 2017, the EU released a number of Brexit negotiation position papers, including one regarding Intellectual property rights which is of significant importance to the IP intensive Life Sciences industry.  The paper sets out the position of the EU27 on existing Intellectual Property (“IP”) rights and the exhaustion of those rights at the withdrawal date.  Read More